| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 Program of Cancer and Developmental Therapeutics, Buck Institute for Age Research, Novato, California and 2 Department of Urology, University of California at San Francisco, San Francisco, California
Requests for reprints: Christopher C. Benz, Program of Cancer and Developmental Therapeutics, Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945. Phone: 415-209-2092; Fax: 415-209-2232; E-mail: cbenz{at}buckinstitute.org.
Improved understanding of the molecular mechanisms by which small-molecule inhibitors of histone deacetylases (HDAC) induce programs, such as cellular differentiation and apoptosis, would undoubtedly assist their clinical development as anticancer agents. As modulators of gene transcript levels, HDAC inhibitors (HDACi) typically affect only 5% to 10% of actively transcribed genes with approximately as many mRNA transcripts being up-regulated as down-regulated. Using microRNA (miRNA) array analysis, we report rapid alteration of miRNA levels in response to the potent hydroxamic acid HDACi LAQ824 in the breast cancer cell line SKBr3. Within 5 hours of exposure to a proapoptotic dose of LAQ824, significant changes were measured in 40% of the >60 different miRNA species expressed in SKBr3 cells with 22 miRNA species down-regulated and 5 miRNAs up-regulated. To explore a potential functional link between HDACi induced mRNA up-regulation and miRNA down-regulation, antisense experiments were done against miR-27a and miR-27b, both abundantly expressed and down-regulated in SKBr3 cells by LAQ824. Correlating a set of genes previously determined by cDNA array analysis to be rapidly up-regulated by LAQ824 in SKBr3 with a database of potential 3' untranslated region miRNA binding elements, two genes containing putative miR-27 anchor elements were identified as transcriptionally up-regulated following miR-27 antisense transfection, ZBTB10/RINZF, a Sp1 repressor, and RYBP/DEDAF, an apoptotic facilitator. These findings emphasize the importance of post-transcriptional mRNA regulation by HDACi in addition to their established effects on promoter-driven gene expression. (Cancer Res 2006; 66(3): 1277-81)
This article has been cited by other articles:
|
|
 |
|
  M. V. Iorio and C. M. Croce MicroRNAs in Cancer: Small Molecules With a Huge Impact J. Clin. Oncol., December 1, 2009; 27(34): 5848 - 5856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Guo Epigenetics of endometriosis Mol. Hum. Reprod., October 1, 2009; 15(10): 587 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Guttilla and B. A. White Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells J. Biol. Chem., August 28, 2009; 284(35): 23204 - 23216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li, and C. M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res., May 1, 2009; 37(8): 2584 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sampath, G. A. Calin, V. K. Puduvalli, G. Gopisetty, C. Taccioli, C.-G. Liu, B. Ewald, C. Liu, M. J. Keating, and W. Plunkett Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation Blood, April 16, 2009; 113(16): 3744 - 3753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Toyota, H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, Y. Shinomura, and T. Tokino Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer Cancer Res., June 1, 2008; 68(11): 4123 - 4132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sun, Z. Estrov, Y. Ji, K. R. Coombes, D. H. Harris, and R. Kurzrock Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Mol. Cancer Ther., March 1, 2008; 7(3): 464 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Schrump, M. R. Fischette, D. M. Nguyen, M. Zhao, X. Li, T. F. Kunst, A. Hancox, J. A. Hong, G. A. Chen, E. Kruchin, et al. Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin Clin. Cancer Res., January 1, 2008; 14(1): 188 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mi, J. Lu, M. Sun, Z. Li, H. Zhang, M. B. Neilly, Y. Wang, Z. Qian, J. Jin, Y. Zhang, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia PNAS, December 11, 2007; 104(50): 19971 - 19976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Mertens-Talcott, S. Chintharlapalli, X. Li, and S. Safe The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer Cells Cancer Res., November 15, 2007; 67(22): 11001 - 11011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Goga and C. Benz Anti-Oncomir Suppression of Tumor Phenotypes Mol. Interv., August 1, 2007; 7(4): 199 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Porkka, M. J. Pfeiffer, K. K. Waltering, R. L. Vessella, T. L.J. Tammela, and T. Visakorpi MicroRNA Expression Profiling in Prostate Cancer Cancer Res., July 1, 2007; 67(13): 6130 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rada-Iglesias, S. Enroth, A. Ameur, C. M. Koch, G. K. Clelland, P. Respuela-Alonso, S. Wilcox, O. M. Dovey, P. D. Ellis, C. F. Langford, et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes Genome Res., June 1, 2007; 17(6): 708 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R. W. Sobol, and S. Dacic Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma Cancer Res., March 1, 2007; 67(5): 2345 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Scott, A. Goga, D. Bhaumik, C. E. Berger, C. S. Sullivan, and C. C. Benz Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b J. Biol. Chem., January 12, 2007; 282(2): 1479 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Stanton, L. J. McReynolds, T. Evans, and N. Schreiber-Agus Yaf2 Inhibits Caspase 8-mediated Apoptosis and Regulates Cell Survival during Zebrafish Embryogenesis J. Biol. Chem., September 29, 2006; 281(39): 28782 - 28793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Diederichs and D. A. Haber Sequence Variations of MicroRNAs in Human Cancer: Alterations in Predicted Secondary Structure Do Not Affect Processing. Cancer Res., June 15, 2006; 66(12): 6097 - 6104. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
